In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling
about
Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia.In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model.Nylon-3 polymers with selective antifungal activityProteomic Analysis of Cellular and Membrane Proteins in Fluconazole-Resistant Candida glabrataEfflux-mediated antifungal drug resistance.Proteomic Analysis of Intracellular and Membrane Proteins From Voriconazole-Resistant Candida glabrataThe contribution of mouse models to our understanding of systemic candidiasis.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Novel strategies against Candida biofilms: interest of synthetic compounds.Structure-activity relationships among antifungal nylon-3 polymers: identification of materials active against drug-resistant strains of Candida albicans.Transcriptional profiling of azole-resistant Candida parapsilosis strainsAneuploid chromosomes are highly unstable during DNA transformation of Candida albicans.Nylon-3 polymers active against drug-resistant Candida albicans biofilms.
P2860
Q36018860-56ADCED2-6B0E-48EA-B946-4634218884CEQ36425025-44B88749-F624-4BA1-998D-927C565D3BFAQ36932989-85E0BC5D-D245-4818-9EF9-1D855835E163Q36933390-F22BC5C7-8C55-49F8-9910-F6B95D78730EQ37105788-D2711105-0A6C-4685-88D2-0B59FCCC2624Q37156645-263E7315-3A4B-4366-8E60-B9E9C0BC1742Q37579679-18D57C58-A8FE-4815-8539-DDF78C15E568Q37852088-28E4FCF1-0B5E-4C62-B094-64CDBDE1302FQ38193337-B1488227-8DF4-4020-BEA3-BD849850F880Q38670904-FEBD653F-71C5-4127-B617-E977AD8A38E0Q38740925-3F4B5E9A-11FE-4C08-BE0F-8AAD68A4CD0FQ42110990-10684C9C-DD28-4D50-994C-4EA8C6E7C103Q42576408-472463BE-EDA4-4583-9524-AE2B75E130FDQ42654484-2FF92020-224B-44EA-937B-FAC38C490FE5
P2860
In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vivo fluconazole pharmacody ...... and transcriptional profiling
@ast
In vivo fluconazole pharmacody ...... and transcriptional profiling
@en
In vivo fluconazole pharmacody ...... and transcriptional profiling
@nl
type
label
In vivo fluconazole pharmacody ...... and transcriptional profiling
@ast
In vivo fluconazole pharmacody ...... and transcriptional profiling
@en
In vivo fluconazole pharmacody ...... and transcriptional profiling
@nl
prefLabel
In vivo fluconazole pharmacody ...... and transcriptional profiling
@ast
In vivo fluconazole pharmacody ...... and transcriptional profiling
@en
In vivo fluconazole pharmacody ...... and transcriptional profiling
@nl
P2093
P2860
P356
P1476
In vivo fluconazole pharmacody ...... and transcriptional profiling
@en
P2093
P2860
P304
P356
10.1128/AAC.01305-05
P407
P50
P577
2006-07-01T00:00:00Z